Source:http://linkedlifedata.com/resource/pubmed/id/20075741
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2010-4-15
|
pubmed:abstractText |
Details of two patients with chronic hepatitis C infection who developed features of Parkinsonism when treated with IFN-alpha2b and ribavirin are reported. The symptoms resolved when treatment was discontinued in one patient but not in the other. Physicians should be alert to the possibility that drug-related Parkinsonism may complicate treatment of hepatitis C infection with antiviral agents; the agent most likely responsible is IFN-alpha2b. Prompt withdrawal of treatment is mandatory but does not always guarantee reversal of the Parkinsonian features.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1473-5687
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
628-31
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20075741-Antiviral Agents,
pubmed-meshheading:20075741-Carcinoma, Hepatocellular,
pubmed-meshheading:20075741-Fatal Outcome,
pubmed-meshheading:20075741-Hepatitis C, Chronic,
pubmed-meshheading:20075741-Humans,
pubmed-meshheading:20075741-Interferon-alpha,
pubmed-meshheading:20075741-Liver Failure,
pubmed-meshheading:20075741-Liver Neoplasms,
pubmed-meshheading:20075741-Male,
pubmed-meshheading:20075741-Middle Aged,
pubmed-meshheading:20075741-Parkinsonian Disorders,
pubmed-meshheading:20075741-Recombinant Proteins
|
pubmed:year |
2010
|
pubmed:articleTitle |
Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases.
|
pubmed:affiliation |
Centre for Hepatology, Department of Medicine, University College London Medical School, University College London, London, UK.
|
pubmed:publicationType |
Journal Article,
Case Reports
|